These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8082010)

  • 1. Endothelin and renal disease progression.
    Remuzzi G; Benigni A
    Exp Nephrol; 1994; 2(2):133. PubMed ID: 8082010
    [No Abstract]   [Full Text] [Related]  

  • 2. The glomerular mesangium: role in initiation and progression of renal injury.
    Shultz PJ; Raij L
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):8-14. PubMed ID: 2024680
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of mesangial cell proliferation by antisense oligodeoxynucleotide targeting preproendothelin-1 mRNA in vitro.
    Li M; Chen Y; Zhang Z; Gao J
    Chin Med J (Engl); 1999 Sep; 112(9):790-3. PubMed ID: 11717946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course and localization of endothelin-1 gene expression in a model of renal disease progression.
    Bruzzi I; Corna D; Zoja C; Orisio S; Schiffrin EL; Cavallotti D; Remuzzi G; Benigni A
    Am J Pathol; 1997 Nov; 151(5):1241-7. PubMed ID: 9358749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prepro-endothelin-1 mRNA and its mature peptide in human appendix.
    Massai L; Carbotti P; Cambiaggi C; Mencarelli M; Migliaccio P; Muscettola M; Grasso G
    Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G340-8. PubMed ID: 12529269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential contribution of endothelin to renal abnormalities in glycerol-induced acute renal failure in rats.
    Shimizu T; Kuroda T; Ikeda M; Hata S; Fujimoto M
    J Pharmacol Exp Ther; 1998 Aug; 286(2):977-83. PubMed ID: 9694958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelins: possibly a new pharmacological approach in cardiovascular diseases, kidney diseases and oncological disorders].
    Kroodsma JM; Rabelink AJ
    Ned Tijdschr Geneeskd; 1997 Sep; 141(38):1806-10. PubMed ID: 9545734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with CsA decreases INF-gamma mRNA and increases pre-pro-ET-1 mRNA in rat kidneys.
    Murer L; Giacomini A; Gambaro G; Del Prete D; Dall'Amico R; Pagetta E; Zacchello G; Anglani F
    Transplant Proc; 1998 Jun; 30(4):950-1. PubMed ID: 9636383
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvianolate inhibits proliferation and endothelin release in cultured rat mesangial cells.
    Xu M; Wang YP; Luo WB; Xuan LJ
    Acta Pharmacol Sin; 2001 Jul; 22(7):629-33. PubMed ID: 11749828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tubular-derived endothelin in the paracrine regulation of renal interstitial fibroblast function.
    Ong AC; Jowett TP; Firth JD; Burton S; Kitamura M; Fine LG
    Exp Nephrol; 1994; 2(2):134. PubMed ID: 8082011
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelin: a mediator of renal disease progression.
    Bruzzi I; Remuzzi G; Benigni A
    J Nephrol; 1997; 10(4):179-83. PubMed ID: 9377723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence and distribution of endothelin-1 gene expression in human kidney.
    Pupilli C; Brunori M; Misciglia N; Selli C; Ianni L; Yanagisawa M; Mannelli M; Serio M
    Am J Physiol; 1994 Oct; 267(4 Pt 2):F679-87. PubMed ID: 7943363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of progression of renal disease: growth factors and related mechanisms.
    Benigni A; Remuzzi G
    J Hypertens Suppl; 1998 Sep; 16(4):S9-12. PubMed ID: 9817186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter.
    Kähler J; Mendel S; Weckmüller J; Orzechowski HD; Mittmann C; Köster R; Paul M; Meinertz T; Münzel T
    J Mol Cell Cardiol; 2000 Aug; 32(8):1429-37. PubMed ID: 10900169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of mesangial cell proliferation and mesangial matrix expansion by antisense oligodeoxynucleotide targeting preproendothelin-1 mRNA in vivo].
    Li M; Chen Y; Zhang Z
    Zhonghua Yi Xue Za Zhi; 1999 Feb; 79(2):133-5. PubMed ID: 11601021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure].
    Orisio S; Zoja C; Remuzzi G
    Ann Ital Med Int; 1993; 8(4):213-7. PubMed ID: 8161475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells.
    Morin C; Asselin C; Boudreau F; Provencher PH
    Biochem Biophys Res Commun; 1998 Mar; 244(2):583-7. PubMed ID: 9514952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
    Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renal toxicity of sustained glomerular protein traffic.
    Benigni A; Zoja C; Remuzzi G
    Lab Invest; 1995 Oct; 73(4):461-8. PubMed ID: 7474916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.